We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-6.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$992B
AUM Growth
-$120B
Cap. Flow
-$16.9B
Cap. Flow %
-1.7%
Top 10 Hldgs %
27.94%
Holding
3,085
New
108
Increased
1,637
Reduced
1,059
Closed
107

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.45B
2
JPM icon
JPMorgan Chase
JPM
+$2.22B
3
TEAM icon
Atlassian
TEAM
+$2.08B
4
NVDA icon
NVIDIA
NVDA
+$1.81B
5
AAPL icon
Apple
AAPL
+$1.67B

Sector Composition

Rank Sector Weight
1 Technology 26.79%
2 Healthcare 17.19%
3 Consumer Discretionary 15.16%
4 Financials 10.74%
5 Communication Services 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCS icon
2226
Century Communities
CCS
$2.04B
$631K ﹤0.01%
11,777
-1,183
-9% -$75.9K
BHE icon
2227
Benchmark Electronics
BHE
$2.89B
$630K ﹤0.01%
25,143
+2,345
+10% +$59.9K
KRYS icon
2228
Krystal Biotech
KRYS
$9.72B
$630K ﹤0.01%
9,473
+1,368
+17% +$85.4K
MHO icon
2229
M/I Homes
MHO
$3.9B
$630K ﹤0.01%
14,206
+2,180
+18% +$111K
PECO icon
2230
Phillips Edison & Co
PECO
$5.2B
$628K ﹤0.01%
+18,257
New +$599K
CNDT icon
2231
Conduent
CNDT
$252M
$626K ﹤0.01%
121,309
+31,382
+35% +$154K
MTOR
2232
DELISTED
MERITOR, Inc.
MTOR
$626K ﹤0.01%
17,601
-3,570,258
-100% -$106M
DGII icon
2233
Digi International
DGII
$3.23B
$624K ﹤0.01%
29,003
+2,462
+9% +$52.6K
GPRE icon
2234
Green Plains
GPRE
$1.09B
$623K ﹤0.01%
20,088
+1,062
+6% +$33.3K
HIFS icon
2235
Hingham Institution for Saving
HIFS
$686M
$621K ﹤0.01%
1,810
+33
+2% +$12.2K
WTBA icon
2236
West Bancorporation
WTBA
$511M
$618K ﹤0.01%
22,725
+4,600
+25% +$136K
CSTL icon
2237
Castle Biosciences
CSTL
$933M
$613K ﹤0.01%
13,667
+3,723
+37% +$154K
RCUS icon
2238
Arcus Biosciences
RCUS
$3.67B
$613K ﹤0.01%
19,437
+1,622
+9% +$54.3K
WSR
2239
DELISTED
Whitestone REIT
WSR
$613K ﹤0.01%
46,261
+1,121
+2% +$12.9K
WIRE
2240
DELISTED
Encore Wire Corp
WIRE
$612K ﹤0.01%
5,367
+423
+9% +$50.8K
MRC
2241
DELISTED
MRC Global
MRC
$610K ﹤0.01%
51,212
+1,700
+3% +$15.9K
VRRM icon
2242
Verra Mobility
VRRM
$731M
$610K ﹤0.01%
37,479
+3,835
+11% +$61.7K
TBI
2243
Trueblue
TBI
$309M
$608K ﹤0.01%
21,057
+711
+3% +$19.5K
TCMD icon
2244
Tactile Systems Technology
TCMD
$537M
$606K ﹤0.01%
30,048
+13,001
+76% +$227K
MYRG icon
2245
MYR Group
MYRG
$5.1B
$605K ﹤0.01%
6,437
+300
+5% +$28.6K
VIA
2246
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$605K ﹤0.01%
14,697
-103
-0.7% -$5.47K
KURA icon
2247
Kura Oncology
KURA
$896M
$601K ﹤0.01%
37,373
+15,296
+69% +$221K
WOR icon
2248
Worthington Enterprises
WOR
$2.85B
$600K ﹤0.01%
18,919
-2,555
-12% -$88.2K
ICLR icon
2249
Icon
ICLR
$12.9B
$598K ﹤0.01%
2,460
+279
+13% +$69.9K
PRPC
2250
DELISTED
CC Neuberger Principal Holdings III
PRPC
$598K ﹤0.01%
60,625

Similar funds

T. Rowe Price Associates's Q1 2022 Portfolio in Review

As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.

T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
  • T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
  • T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
  • T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
  • T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
  • T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
  • T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.

Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.